First Tracks Biotherapeutics TRAX
NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

First Tracks Biotherapeutics (TRAX) Current Assets (2024 - 2026)

Updated

First Tracks Biotherapeutics (TRAX) recorded Current Assets of $165.72 million in Q3 2026, down 6.8% from the prior quarter.

Analysis

First Tracks Biotherapeutics (TRAX) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, First Tracks Biotherapeutics reported Current Assets of $316.4 million, down 18.9% from FY2024.

  • Across earlier years, Current Assets came in at $389.93 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at $177.75 million (Q2 2026), $289.4 million (Q1 2026) and $316.4 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 56.35 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 37.48 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 31.45 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 16.55 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 45.01 Bn
10 First Tracks Biotherapeutics 1.66 Bn 740.14 Mn - 165.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 165.72 Mn
Jun 30, 2026 177.75 Mn
Mar 31, 2026 289.40 Mn
Dec 31, 2025 316.40 Mn
Dec 31, 2024 389.93 Mn
API Access

First Tracks Biotherapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TRAX&period=max&api_key=YOUR_API_KEY